Structure Therapeutics (GPCR) News Today $24.55 -0.10 (-0.41%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$24.12 -0.44 (-1.77%) As of 05/23/2025 07:12 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock GPCR Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Zimmer Partners LP Sells 154,200 Shares of Structure Therapeutics Inc. (NASDAQ:GPCR)Zimmer Partners LP trimmed its position in shares of Structure Therapeutics Inc. (NASDAQ:GPCR - Free Report) by 73.0% during the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 56,900 shares of the company's stock after selling 154,200 shares during the quarter. ZiMay 23 at 6:16 AM | marketbeat.comVestal Point Capital LP Raises Stock Holdings in Structure Therapeutics Inc. (NASDAQ:GPCR)Vestal Point Capital LP boosted its holdings in shares of Structure Therapeutics Inc. (NASDAQ:GPCR - Free Report) by 50.0% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,725,000 shares of the company's stMay 21 at 8:14 AM | marketbeat.comWexford Capital LP Sells 16,351 Shares of Structure Therapeutics Inc. (NASDAQ:GPCR)Wexford Capital LP lessened its position in Structure Therapeutics Inc. (NASDAQ:GPCR - Free Report) by 16.6% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 81,872 shares of the company's stock after sellingMay 21 at 7:07 AM | marketbeat.comTema Etfs LLC Acquires New Shares in Structure Therapeutics Inc. (NASDAQ:GPCR)Tema Etfs LLC purchased a new stake in shares of Structure Therapeutics Inc. (NASDAQ:GPCR - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 44,343 shares of the company's stock, valuedMay 20, 2025 | marketbeat.comStructure Therapeutics Inc. (NASDAQ:GPCR) Receives Average Rating of "Buy" from BrokeragesMay 19, 2025 | americanbankingnews.comStructure Therapeutics Inc. (NASDAQ:GPCR) Shares Sold by Point72 Europe London LLPPoint72 Europe London LLP decreased its position in Structure Therapeutics Inc. (NASDAQ:GPCR - Free Report) by 29.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 31,420 shares of the company's stock aftMay 18, 2025 | marketbeat.comStructure Therapeutics Inc. (NASDAQ:GPCR) Receives Average Recommendation of "Buy" from AnalystsShares of Structure Therapeutics Inc. (NASDAQ:GPCR - Get Free Report) have earned a consensus recommendation of "Buy" from the nine brokerages that are presently covering the company, Marketbeat Ratings reports. Nine equities research analysts have rated the stock with a buy rating. The average 12May 16, 2025 | marketbeat.comWhat is HC Wainwright's Forecast for GPCR FY2025 Earnings?May 16, 2025 | americanbankingnews.comStructure Therapeutics Inc. (NASDAQ:GPCR) Holdings Boosted by Janus Henderson Group PLCJanus Henderson Group PLC boosted its position in shares of Structure Therapeutics Inc. (NASDAQ:GPCR - Free Report) by 5.1% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 4,159,888 shares of the company's stock after purchaMay 15, 2025 | marketbeat.comEnsign Peak Advisors Inc Has $8.36 Million Stock Holdings in Structure Therapeutics Inc. (NASDAQ:GPCR)Ensign Peak Advisors Inc boosted its position in Structure Therapeutics Inc. (NASDAQ:GPCR - Free Report) by 67.7% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 308,241 shares of the company's stock after purchasing an additional 124,456 shares during the perioMay 15, 2025 | marketbeat.comAmeriprise Financial Inc. Increases Stock Position in Structure Therapeutics Inc. (NASDAQ:GPCR)Ameriprise Financial Inc. grew its stake in shares of Structure Therapeutics Inc. (NASDAQ:GPCR - Free Report) by 29.4% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,420,052 shares of the company's stMay 15, 2025 | marketbeat.comHC Wainwright Issues Pessimistic Forecast for Structure Therapeutics (NASDAQ:GPCR) Stock PriceHC Wainwright lowered their target price on Structure Therapeutics from $80.00 to $75.00 and set a "buy" rating for the company in a report on Monday.May 14, 2025 | marketbeat.comHC Wainwright Has Lowered Expectations for Structure Therapeutics (NASDAQ:GPCR) Stock PriceMay 14, 2025 | americanbankingnews.comThe Manufacturers Life Insurance Company Has $1.58 Million Position in Structure Therapeutics Inc. (NASDAQ:GPCR)The Manufacturers Life Insurance Company lowered its stake in shares of Structure Therapeutics Inc. (NASDAQ:GPCR - Free Report) by 32.9% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 58,24May 13, 2025 | marketbeat.comFY2025 Earnings Forecast for GPCR Issued By Leerink PartnrsStructure Therapeutics Inc. (NASDAQ:GPCR - Free Report) - Equities research analysts at Leerink Partnrs lowered their FY2025 EPS estimates for shares of Structure Therapeutics in a report released on Thursday, May 8th. Leerink Partnrs analyst D. Risinger now expects that the company will post earMay 13, 2025 | marketbeat.comVoya Investment Management LLC Sells 20,830 Shares of Structure Therapeutics Inc. (NASDAQ:GPCR)Voya Investment Management LLC lowered its stake in shares of Structure Therapeutics Inc. (NASDAQ:GPCR - Free Report) by 44.5% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 25,940 shares of the company's stock after sellMay 11, 2025 | marketbeat.comDeerfield Management Company L.P. Series C Has $10.13 Million Stock Holdings in Structure Therapeutics Inc. (NASDAQ:GPCR)Deerfield Management Company L.P. Series C lowered its position in Structure Therapeutics Inc. (NASDAQ:GPCR - Free Report) by 55.8% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 373,407 shares of the cMay 10, 2025 | marketbeat.comDriehaus Capital Management LLC Decreases Position in Structure Therapeutics Inc. (NASDAQ:GPCR)Driehaus Capital Management LLC decreased its position in shares of Structure Therapeutics Inc. (NASDAQ:GPCR - Free Report) by 18.6% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 2,057,410 shares of the company's stock after selling 469,020 shares duriMay 10, 2025 | marketbeat.comDeep Track Capital LP Acquires 1,579,492 Shares of Structure Therapeutics Inc. (NASDAQ:GPCR)Deep Track Capital LP raised its holdings in Structure Therapeutics Inc. (NASDAQ:GPCR - Free Report) by 129.4% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 2,800,000 shares of the company's stock after purchasing aMay 9, 2025 | marketbeat.comStructure Therapeutics Reports First Quarter 2025 Financial Results and Recent HighlightsMay 9, 2025 | finance.yahoo.comBaker BROS. Advisors LP Acquires 276,065 Shares of Structure Therapeutics Inc. (NASDAQ:GPCR)Baker BROS. Advisors LP grew its holdings in shares of Structure Therapeutics Inc. (NASDAQ:GPCR - Free Report) by 322.9% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 361,565 shares of the company's stock after buying an additionaMay 6, 2025 | marketbeat.comBVF Inc. IL Reduces Stock Position in Structure Therapeutics Inc. (NASDAQ:GPCR)BVF Inc. IL cut its position in Structure Therapeutics Inc. (NASDAQ:GPCR - Free Report) by 20.9% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 1,771,417 shares of the company's stock after selling 467,569 shares during the period. Structure TheMay 6, 2025 | marketbeat.comBellevue Group AG Reduces Stake in Structure Therapeutics Inc. (NASDAQ:GPCR)Bellevue Group AG trimmed its position in shares of Structure Therapeutics Inc. (NASDAQ:GPCR - Free Report) by 23.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 485,050 shares of the company's stock after selMay 6, 2025 | marketbeat.comStructure Therapeutics (NASDAQ:GPCR) Coverage Initiated by Analysts at CitigroupCitigroup initiated coverage on Structure Therapeutics in a report on Friday. They issued a "buy" rating and a $60.00 price target for the company.May 4, 2025 | marketbeat.comBoxer Capital Management LLC Makes New $13.56 Million Investment in Structure Therapeutics Inc. (NASDAQ:GPCR)Boxer Capital Management LLC acquired a new stake in shares of Structure Therapeutics Inc. (NASDAQ:GPCR - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 500,000 shaMay 4, 2025 | marketbeat.comStructure Therapeutics Inc. (NASDAQ:GPCR) Shares Sold by RA Capital Management L.P.RA Capital Management L.P. cut its stake in shares of Structure Therapeutics Inc. (NASDAQ:GPCR - Free Report) by 20.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,517,418 shares of the company's stMay 3, 2025 | marketbeat.comStructure Therapeutics (GPCR) to Release Quarterly Earnings on ThursdayStructure Therapeutics (NASDAQ:GPCR) will be releasing its Q1 2025 earnings before the market opens on Thursday, May 8. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-8-structure-therapeutics-inc-american-depositary-shares-stock/)May 3, 2025 | marketbeat.comStructure Therapeutics (NASDAQ:GPCR) Sets New 12-Month High - Should You Buy?Structure Therapeutics (NASDAQ:GPCR) Reaches New 1-Year High - Time to Buy?May 3, 2025 | marketbeat.comCitigroup Initiates Coverage of Structure Therapeutics Inc. - Depositary Receipt () (GPCR) with Buy RecommendationMay 3, 2025 | msn.comStructure draws new Buy at Citi on oral obesity drug pipelineMay 2, 2025 | msn.comMonashee Investment Management LLC Sells 27,608 Shares of Structure Therapeutics Inc. (NASDAQ:GPCR)Monashee Investment Management LLC trimmed its holdings in Structure Therapeutics Inc. (NASDAQ:GPCR - Free Report) by 17.3% in the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 132,000 shares of the company's stock after selling 27,608 shares durinMay 2, 2025 | marketbeat.comStructure Therapeutics Inc. (NASDAQ:GPCR) Holdings Decreased by Price T Rowe Associates Inc. MDPrice T Rowe Associates Inc. MD trimmed its position in Structure Therapeutics Inc. (NASDAQ:GPCR - Free Report) by 33.1% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,394,306 shares of the company's stock after selMay 2, 2025 | marketbeat.com24,530 Shares in Structure Therapeutics Inc. (NASDAQ:GPCR) Acquired by Mariner LLCMariner LLC bought a new position in Structure Therapeutics Inc. (NASDAQ:GPCR - Free Report) during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 24,530 shares of the company's stock, valued at approximately $665,000. Other hedgeMay 2, 2025 | marketbeat.comBarclays PLC Increases Stock Holdings in Structure Therapeutics Inc. (NASDAQ:GPCR)Barclays PLC boosted its position in shares of Structure Therapeutics Inc. (NASDAQ:GPCR - Free Report) by 42.6% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 115,671 shares of the company's stock after purchMay 2, 2025 | marketbeat.comStructure Therapeutics (NASDAQ:GPCR) Trading 5.2% Higher - Here's WhyStructure Therapeutics (NASDAQ:GPCR) Trading Up 5.2% - Should You Buy?May 1, 2025 | marketbeat.comFirst Light Asset Management LLC Trims Stock Position in Structure Therapeutics Inc. (NASDAQ:GPCR)First Light Asset Management LLC lowered its stake in shares of Structure Therapeutics Inc. (NASDAQ:GPCR - Free Report) by 21.2% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 398,855 shares of the company'April 30, 2025 | marketbeat.comForesite Capital Management VI LLC Acquires New Position in Structure Therapeutics Inc. (NASDAQ:GPCR)Foresite Capital Management VI LLC acquired a new stake in shares of Structure Therapeutics Inc. (NASDAQ:GPCR - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 420,000 shares of the company's stock, valApril 30, 2025 | marketbeat.comBoothbay Fund Management LLC Has $2.26 Million Holdings in Structure Therapeutics Inc. (NASDAQ:GPCR)Boothbay Fund Management LLC grew its stake in Structure Therapeutics Inc. (NASDAQ:GPCR - Free Report) by 147.0% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 83,148 shares of the company's stock after buying an addiApril 30, 2025 | marketbeat.comViking among notable gainers as Pfizer raises deal prospectsApril 29, 2025 | msn.comIs Structure Therapeutics Inc. (NASDAQ:GPCR) the Most Promising Small-Cap Stock According to Analysts?April 26, 2025 | msn.comInvesco Ltd. Grows Stock Position in Structure Therapeutics Inc. (NASDAQ:GPCR)Invesco Ltd. lifted its holdings in shares of Structure Therapeutics Inc. (NASDAQ:GPCR - Free Report) by 4.1% during the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 371,767 shares of the company's stock after acquiring an additional 14,559 shares during theApril 25, 2025 | marketbeat.comH.C. Wainwright maintains buy on Structure Therapeutics sharesApril 24, 2025 | uk.investing.comStructure Therapeutics (NASDAQ:GPCR) Shares Down 3% - Here's What HappenedStructure Therapeutics (NASDAQ:GPCR) Stock Price Down 3% - Here's What HappenedApril 24, 2025 | marketbeat.comHC Wainwright Reiterates Buy Rating for Structure Therapeutics (NASDAQ:GPCR)HC Wainwright reaffirmed a "buy" rating and set a $80.00 price objective on shares of Structure Therapeutics in a report on Tuesday.April 24, 2025 | marketbeat.comSilverarc Capital Management LLC Has $4.13 Million Position in Structure Therapeutics Inc. (NASDAQ:GPCR)Silverarc Capital Management LLC grew its position in Structure Therapeutics Inc. (NASDAQ:GPCR - Free Report) by 116.1% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 152,395 shares of the company's stock after purchasing an additionaApril 24, 2025 | marketbeat.comStructure Therapeutics (NASDAQ:GPCR) Stock Price Up 5.9% - Should You Buy?Structure Therapeutics (NASDAQ:GPCR) Trading 5.9% Higher - Still a Buy?April 23, 2025 | marketbeat.comRock Springs Capital Management LP Boosts Holdings in Structure Therapeutics Inc. (NASDAQ:GPCR)Rock Springs Capital Management LP raised its holdings in Structure Therapeutics Inc. (NASDAQ:GPCR - Free Report) by 1.6% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,080,963 shares of the compApril 23, 2025 | marketbeat.comCapital International Investors Purchases 103,059 Shares of Structure Therapeutics Inc. (NASDAQ:GPCR)Capital International Investors raised its position in shares of Structure Therapeutics Inc. (NASDAQ:GPCR - Free Report) by 6.8% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,619,081 shareApril 23, 2025 | marketbeat.comMarshall Wace LLP Grows Stock Position in Structure Therapeutics Inc. (NASDAQ:GPCR)Marshall Wace LLP increased its holdings in Structure Therapeutics Inc. (NASDAQ:GPCR - Free Report) by 339.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 583,207 shares of the company's stock after buyApril 23, 2025 | marketbeat.comStructure Therapeutics Inc. (NASDAQ:GPCR) Given Consensus Recommendation of "Buy" by AnalystsShares of Structure Therapeutics Inc. (NASDAQ:GPCR - Get Free Report) have been given an average rating of "Buy" by the eight brokerages that are presently covering the firm, MarketBeat Ratings reports. Eight investment analysts have rated the stock with a buy rating. The average twelve-month pricApril 21, 2025 | marketbeat.com Get Structure Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for GPCR and its competitors with MarketBeat's FREE daily newsletter. Email Address GPCR Media Mentions By Week GPCR Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GPCR News Sentiment▼1.100.75▲Average Medical News Sentiment GPCR News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GPCR Articles This Week▼65▲GPCR Articles Average Week Get Structure Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for GPCR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Telix Pharmaceuticals Limited American Depositary Shares News Verona Pharma News Lantheus News Axsome Therapeutics News TG Therapeutics News Grifols News Nuvalent News ADMA Biologics News Vaxcyte News Krystal Biotech News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GPCR) was last updated on 5/24/2025 by MarketBeat.com Staff From Our PartnersTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored$19 for a FULL YEAR of stock picks?!Invest in Musk's AI Play With Just $100 You don't need deep pockets to ride the next wave of AI wealth. ...Behind the Markets | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredAfter Monday, price goes up 600% (hurry)Right now, for a limited time… You can get up to 52 Money Monday trades for just $7! Thanks to Wall Street’...Timothy Sykes | SponsoredMemorial Day Sale! Save 85% on Weiss Crypto Investor!President Trump just made his first big crypto move … Announcing the creation of a national strategic reser...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Structure Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Structure Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy GPCR Stock Free GPCR Stock Alerts